Experienced in Hepatic Ischemia

Marco Valgimigli

Erasmus MC
Rotterdam, ZH, NL 
Experienced in Hepatic Ischemia
Erasmus MC
Rotterdam, ZH, NL 
OverviewLocationsClinical Research

Overview

Marco Valgimigli practices in Rotterdam, Netherlands. Mr. Valgimigli is rated as an Experienced expert by MediFind in the treatment of Hepatic Ischemia. His top areas of expertise are Acute Coronary Syndrome, Heart Attack, Coronary Heart Disease, Percutaneous Coronary Intervention (PCI), and Stent Placement.

His clinical research consists of co-authoring 656 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Hepatic Ischemia.

Gender
Male

Locations

Erasmus MC
Rotterdam, ZH, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

The MOCA I Study - Microvascular Obstruction with CoFI™ System Assessment
The MOCA I Study - Microvascular Obstruction with CoFI™ System Assessment
Enrollment Status: Completed
Publish Date: March 19, 2025
Intervention Type: Device
Study Phase: Phase 1
A Phase 3, Multicenter, Open-Label, Single-Arm Study of Bentracimab (PB2452) in Ticagrelor-Treated Patients With Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure (REVERSE-IT Trial)
A Phase 3, Multicenter, Open-Label, Single-Arm Study of Bentracimab (PB2452) in Ticagrelor-Treated Patients With Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure (REVERSE-IT Trial)
Enrollment Status: Completed
Publish Date: October 21, 2024
Intervention Type: Drug
Study Phase: Phase 3
GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation
GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation
Enrollment Status: Completed
Publish Date: March 15, 2022
Intervention Type: Drug
Study Phase: Phase 3
Everolimus-eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy in Heart Transplant Recipients: A Prospective Multicenter Pilot Study
Everolimus-eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy in Heart Transplant Recipients: A Prospective Multicenter Pilot Study
Enrollment Status: Completed
Publish Date: September 30, 2021
Intervention Type: Device
Study Phase: Phase 4
Randomized Comparison Between a DES and a BMS to Assess Neointimal Coverage by OCT Evaluation
Randomized Comparison Between a DES and a BMS to Assess Neointimal Coverage by OCT Evaluation
Enrollment Status: Completed
Publish Date: April 30, 2018
Intervention Type: Device
Study Phase: Not Applicable
View 4 Less Clinical Trials

656 Total Publications

Validation of the Mayo Clinic Percutaneous Coronary Intervention Risk Prediction Score in Patients With Acute Coronary Syndrome.
Validation of the Mayo Clinic Percutaneous Coronary Intervention Risk Prediction Score in Patients With Acute Coronary Syndrome.
Journal: Journal of the American Heart Association
Published: October 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Valgimigli's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 26 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile